Network·Venture Capital
BrightEdge is the innovation and impact investment arm of the American Cancer Society that invests in actionable and scalable solutions addressing unmet needs in cancer care while generating financial returns and driving scientific, social, and sustainable impact.
This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.